(Q53221286)

English

Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leu

scientific article published on 31 January 2008

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239620%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239620%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

multicenter clinical trial

1 reference

based on heuristic

inferred from title

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239620%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239620%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239620%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Jacques Van Dongen

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239620%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author name string

T Flohr

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239620%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

A Schrauder

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239620%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

G Cazzaniga

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239620%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

R Panzer-Grümayer

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239620%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

V van der Velden

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239620%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

S Fischer

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239620%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

M Stanulla

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239620%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

R Sutton

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239620%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

R Koehler

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239620%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

M Zimmermann

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239620%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

M G Valsecchi

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239620%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

H Gadner

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239620%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

G Masera

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239620%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

M Schrappe

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239620%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

A Biondi

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239620%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

C R Bartram

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239620%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

International BFM Study Group (I-BFM-SG)

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239620%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

publication date

31 January 2008

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239620%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239620%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

22

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239620%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239620%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

771-782

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239620%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) acute lymphoblastic leukemia studies, 1982-1995.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.5

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Münster.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.5

7 January 2021

based on heuristic

inferred from DOI database lookup

Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983-1995.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.5

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up of Dutch Childhood Leukemia Study Group (DCLSG) protocols for children with acute lymphoblastic leukemia, 1984-1991

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.5

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981-1995)

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.5

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report. Children Leukemia Cooperative Group

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.5

7 January 2021

based on heuristic

inferred from DOI database lookup

Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation. Nordic Society of Pediatric Haematology and Oncology (NOPHO).

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.5

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term results of treatment studies for childhood acute lymphoblastic leukemia: Pediatric Oncology Group studies from 1986-1994

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.5

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research Hospital

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.5

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980-1997. Medical Research Council Childhood Leukaemia Working Party.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.5

7 January 2021

based on heuristic

inferred from DOI database lookup

Why and how to quantify minimal residual disease in acute lymphoblastic leukemia?

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.5

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular monitoring of residual disease using antigen receptor genes in childhood acute lymphoblastic leukaemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.5

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.5

7 January 2021

based on heuristic

inferred from DOI database lookup

Importance of minimal residual disease testing during the second year of therapy for children with acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.5

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.5

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.5

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiplex PCR--a rapid screening method for detection of gene rearrangements in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.5

7 January 2021

based on heuristic

inferred from DOI database lookup

Suitable DNA isolation method for the detection of minimal residual disease by PCR techniques

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.5

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.5

7 January 2021

based on heuristic

inferred from DOI database lookup

Precursor-B-ALL with D(H)-J(H) gene rearrangements have an immature immunogenotype with a high frequency of oligoclonality and hyperdiploidy of chromosome 14

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.5

7 January 2021

based on heuristic

inferred from DOI database lookup

Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.5

7 January 2021

based on heuristic

inferred from DOI database lookup

Heteroduplex PCR analysis of rearranged T cell receptor genes for clonality assessment in suspect T cell proliferations

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.5

7 January 2021

based on heuristic

inferred from DOI database lookup

Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.5

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center setting.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.5

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.5

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia: significance of low leukocyte counts with blasts or traumatic lumbar puncture

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.5

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved outcome in high-risk childhood acute lymphoblastic leukemia defined by prednisone-poor response treated with double Berlin-Frankfurt-Muenster protocol II.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.5

7 January 2021

based on heuristic

inferred from DOI database lookup

Minimal residual disease after intensive induction therapy in childhood acute lymphoblastic leukemia predicts outcome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.5

7 January 2021

based on heuristic

inferred from DOI database lookup

Precise quantification of minimal residual disease at day 29 allows identification of children with acute lymphoblastic leukemia and an excellent outcome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.5

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.5

7 January 2021

based on heuristic

inferred from DOI database lookup

Rearranged T-cell receptor beta genes represent powerful targets for quantification of minimal residual disease in childhood and adult T-cell acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.5

7 January 2021

based on heuristic

inferred from DOI database lookup

Age-related patterns of immunoglobulin and T-cell receptor gene rearrangements in precursor-B-ALL: implications for detection of minimal residual disease

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.5

7 January 2021

based on heuristic

inferred from DOI database lookup

TCRB gene rearrangements in childhood and adult precursor-B-ALL: frequency, applicability as MRD-PCR target, and stability between diagnosis and relapse

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.5

7 January 2021

based on heuristic

inferred from DOI database lookup

Cross-lineage T cell receptor gene rearrangements occur in more than ninety percent of childhood precursor-B acute lymphoblastic leukemias: alternative PCR targets for detection of minimal residual disease

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.5

7 January 2021

based on heuristic

inferred from DOI database lookup

Heterogeneity in junctional regions of immunoglobulin kappa deleting element rearrangements in B cell leukemias: a new molecular target for detection of minimal residual disease

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.5

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved assessment of minimal residual disease in B cell malignancies using fluorogenic consensus probes for real-time quantitative PCR

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.5

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunoglobulin kappa deleting element rearrangements in precursor-B acute lymphoblastic leukemia are stable targets for detection of minimal residual disease by real-time quantitative PCR

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.5

7 January 2021

based on heuristic

inferred from DOI database lookup

T cell receptor gamma gene rearrangements as targets for detection of minimal residual disease in acute lymphoblastic leukemia by real-time quantitative PCR analysis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.5

7 January 2021

based on heuristic

inferred from DOI database lookup

T cell receptor gamma (TCRG) gene rearrangements in T cell acute lymphoblastic leukemia refelct 'end-stage' recombinations: implications for minimal residual disease monitoring

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.5

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of immunoglobulin and T cell receptor genes. Part II: Possibilities and limitations in the diagnosis and management of lymphoproliferative diseases and related disorders

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.5

7 January 2021

based on heuristic

inferred from DOI database lookup

Site-specific deletions involving the tal-1 and sil genes are restricted to cells of the T cell receptor alpha/beta lineage: T cell receptor delta gene deletion mechanism affects multiple genes.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.5

7 January 2021

based on heuristic

inferred from DOI database lookup

Minimal residual disease studies by flow cytometry in acute leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.5

7 January 2021

based on heuristic

inferred from DOI database lookup

Superiority of allogeneic hematopoietic stem-cell transplantation compared with chemotherapy alone in high-risk childhood T-cell acute lymphoblastic leukemia: results from ALL-BFM 90 and 95.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.5

7 January 2021

based on heuristic

inferred from DOI database lookup

Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53221286&oldid=2212035890"